Modulating Cerebrospinal Fluid Composition in Neurodegenerative Processes: Modern Drug Delivery and Clearance...

Area of Science:

• Neuroscience
• Neurology
• Biochemistry

Background:

• Secondary damage following neurodegenerative diseases, TBI, and stroke progresses long-term.
• Cerebrospinal fluid (CSF) is a key mediator in spreading cytotoxic factors and pathological aggregates.
• Blood-brain and blood-CSF barrier dysfunction exacerbate neurodegeneration by increasing harmful CSF agents.

Purpose of the Study:

• To review molecular mechanisms of secondary brain injury.
• To examine the role of barrier systems in CSF homeostasis.
• To discuss current and innovative therapeutic strategies targeting CSF composition for neuroprotection and personalized medicine.

Main Methods:

• Literature review of molecular mechanisms in secondary brain injury.
• Analysis of the role of CNS barriers in CSF regulation.
• Survey of therapeutic strategies including drug delivery systems and CSF modulation.

Main Results:

• CSF actively mediates the spread of cytotoxic factors (ROS, glutamate, cytokines) and protein aggregates (Aβ, tau, α-synuclein).
• Impaired barrier function leads to accumulation of damaging agents in CSF, accelerating neurodegeneration.
• Innovative drug delivery methods and CSF modulation show therapeutic potential.

Conclusions:

• CSF is a critical therapeutic target for neurodegenerative diseases.
• Targeting CSF composition offers a window for neuroprotection and personalized treatment.
• CSF analysis holds potential for early diagnosis and monitoring of neurological conditions.